Earnings Update: Vidrala, S.A. (BME:VID) Just Reported Its Half-Yearly Results And Analysts Are Updating Their Forecasts

Vidrala, S.A. (BME:VID) shareholders are probably feeling a little disappointed, since its shares fell 5.3% to €86.00 in the week after its latest half-year results. Results were roughly in line with estimates, with revenues of €755m and statutory earnings per share of €5.95. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Taking into account the latest results, Vidrala's eleven analysts currently expect revenues in 2026 to be €1.52b, approximately in line with the last 12 months. Statutory earnings per share are predicted to soar 23% to €6.47. Before this earnings report, the analysts had been forecasting revenues of €1.52b and earnings per share (EPS) of €6.48 in 2026. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.

See our latest analysis for Vidrala

It will come as no surprise then, to learn that the consensus price target is largely unchanged at €104. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. The most optimistic Vidrala analyst has a price target of €124 per share, while the most pessimistic values it at €86.00. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Vidrala shareholders.

Of course, another way to look at these forecasts is to place them into context against the industry itself. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 0.03% by the end of 2026. This indicates a significant reduction from annual growth of 7.4% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 3.0% annually for the foreseeable future. It's pretty clear that Vidrala's revenues are expected to perform substantially worse than the wider industry.

The Bottom Line

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Vidrala's revenue is expected to perform worse than the wider industry. The consensus price target held steady at €104, with the latest estimates not enough to have an impact on their price targets.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Vidrala analysts - going out to 2028, and you can see them free on our platform here.

It might also be worth considering whether Vidrala's debt load is appropriate, using our debt analysis tools on the Simply Wall St platform, here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.